AOD-9604 in Sitou — Fat Loss Peptide Research Guide
AOD-9604 research guide for Sitou. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
AOD-9604 isn't available on pharmacy shelves in Sitou or most other cities — this is a specialist compound supplied via a dedicated online market. This matters because AOD-9604 quality ranges widely across the market — from analytically confirmed high-purity product to mislabeled or underdosed compounds — and the vendor is the entire quality system. A legitimate AOD-9604 supplier's COA needs to show HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all corresponding to the vial you receive. The sections below cover what Sitou researchers need to know about sourcing, verifying, and handling AOD-9604 for scientific research use.
AOD-9604 Mechanisms Explained
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: AOD-9604 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Sitou comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
Where to Buy AOD-9604 — A Researcher's Guide
The most reliable path to quality AOD-9604 is starting with community forums — peptide forums aggregate real purchasing experience that are more trustworthy than marketing materials. When reviewing a AOD-9604 COA, verify: the batch number matches your product, HPLC purity is ≥98%, mass spec identifies the correct molecular weight, and endotoxin levels are at acceptable levels for the intended application. Community reputation in research forums is a valuable complement to COA verification — vendors with consistently positive reports over 12+ months have proved themselves through consistent results. Store lyophilised AOD-9604 at −20°C until ready to use; reconstitute only the amount needed for the near-term protocol and store the rest at −20°C.
Order AOD-9604 — ships to Sitou
COA-verified · International tracking · Research grade
All use of AOD-9604 in Sitou or anywhere is research use only — this compound is not approved for clinical human use, and all handling should follow research laboratory protocols. Proper handling of AOD-9604 requires careful sterile procedure — swabbed septum with alcohol prep pad, new needle for each draw, clean preparation area — and temperature control throughout the entire workflow. Verify the endotoxin level in your AOD-9604 batch COA before any injectable research application — look for results stated as EU/mg and verify they are within the acceptable range for your research context. For any individual considering AOD-9604 outside a formal research context: speak with a healthcare professional — this compound is unapproved for human therapeutic application and its known risks are not comparable to approved pharmaceuticals.
Frequently Asked Questions
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
